Last updated: August 2, 2025
Introduction
Patent KR102062357, granted by the Korean Intellectual Property Office (KIPO), pertains to innovations in the pharmaceutical domain—specifically, a new formulation or therapeutic method involving a specific drug or compound. Understanding the scope, claims, and broader patent landscape for this patent is essential for stakeholders who are assessing patent protection, potential infringement, or freedom to operate within South Korea and the global market.
This analysis provides an in-depth review of the patent's scope and claims, contextualizing its position within the existing patent landscape, and highlighting strategic considerations for pharmaceutical companies and patent attorneys.
Patent Overview and Context
KR102062357 was granted in late 2022, reflecting recent innovations in pharmaceutical formulation or method of use. It is critical to identify whether this patent covers a compound, a formulation, a method of manufacture, or use-specific indications, as those aspects shape the patent’s enforceability and infringement risk.
While the full text is not provided here, typical claims in such patents include:
- Composition claims (novel drug or formulation)
- Method claims (administration, treatment, or manufacturing processes)
- Use claims (therapeutic indications)
Understanding the precise language of the claims enables accurate scope delineation, which is crucial in evaluating patent strength and potential overlaps with prior art.
Scope and Claims Analysis
Claim Structure and Focus
1. Composition Claims
Most pharmaceutical patents safeguard specific compounds, salts, derivatives, or combination therapies. If KR102062357 pertains to a new chemical entity, its claims likely encompass:
- The active pharmaceutical ingredient (API) with a novel structure
- Specific isotopic labeling or derivatives
- Synergistic combinations with other therapeutic agents
2. Formulation Claims
If the patent pertains to drug formulations, claims may include:
- Novel excipient combinations
- Controlled-release matrices
- Stability-enhanced formulations
These claims tend to specify ratios, excipient types, and manufacturing parameters.
3. Method of Use or Treatment Claims
Claims may also cover specific methods of administration or therapeutic indications, such as:
- Treatment of particular diseases (e.g., cancer, neurodegenerative diseases)
- Specific dosing regimens
- Targeted delivery methods
4. Manufacturing Process Claims
If the invention introduces a novel synthesis route, the claims likely encompass:
- Step-by-step process features
- Specific catalysts or reaction conditions
- Purification techniques
Claim Breadth and Limitations
The scope depends heavily on claim language. Broad claims may cover a wide range of derivatives or formulations but are often more vulnerable to validity challenges. Narrow claims may enhance enforceability but limit exclusivity.
In the context of Korean patent law, claims can be challenged on grounds of novelty, inventive step, or inventive level if they overlap with prior art. Claims combining multiple features might be considered inventive if the combination confers unexpected advantages.
Patent Landscape and Comparative Analysis
A review of the patent landscape reveals several key aspects:
1. Prior Art and Novelty
The scope of KR102062357’s claims likely navigates around prior art references such as previous patents, scientific publications, or clinical reports. A thorough patentability search indicates whether similar compounds, formulations, or methods exist and how this patent distinguishes itself.
2. Related Patent Applications and Grants
Other patents filed in South Korea, the U.S., Europe, and Asia may relate to similar compounds or therapeutic uses. Notably:
- International patents on similar APIs (e.g., WO patents)
- Priority applications in other jurisdictions (e.g., filings in USPTO, EPO)
- Patent families covering different aspects (composition, use, process)
Understanding these relationships helps assess infringement risks and opportunities for licensing or partnerships.
3. Competitor Positioning and Patent Thickets
The South Korean patent landscape for pharmaceuticals is densely populated, especially in oncology, neurology, and metabolic disorders. KR102062357 appears strategically positioned—either as a broad composition patent or a narrow, specific-use patent—impacting freedom to operate for competitors.
Strategic Implications for Stakeholders
- Patent Holders: Can leverage the patent for market exclusivity in South Korea, potentially extending protection via patent term extensions or supplementary protection certificates (SPCs).
- Generic Manufacturers: Must evaluate working-around strategies, including designing around narrow claims or invalidating claims through prior art.
- R&D Teams: Need to analyze the claims to identify potential overlaps with existing compounds or formulations, informing development pathways.
- Legal and Licensing Entities: Can assess opportunities for licensing agreements or infringement litigation based on claim scope.
Conclusion
KR102062357’s claims likely encompass a specific pharmaceutical compound, formulation, or therapeutic method with defined parameters. Its strength and enforceability hinge on claim language precision and differentiation from prior art. The patent landscape indicates a competitive environment where strategic patent prosecution, maintenance, and vigilance are critical.
Operational decision-makers should diligently analyze the claims' scope against their product portfolios and ongoing R&D to maximize patent advantages and mitigate risks.
Key Takeaways
- The scope of KR102062357 depends heavily on the precise wording of composition, method, and use claims; detailed claim analysis is advisable.
- Its position within the patent landscape reflects ongoing competition in targeted therapeutic areas, emphasizing the importance of patent strategy.
- Broad claims can extend market protection but risk invalidation; narrow claims offer clarity but limited exclusivity.
- Competitors must monitor related patent filings and existing portfolios to develop effective workaround or licensing strategies.
- Continuous patent landscape mapping and prior art searching are essential for informed decision-making in South Korea’s dynamic pharmaceutical patent environment.
FAQs
1. What is the primary focus of patent KR102062357?
KR102062357 appears to protect a specific pharmaceutical compound, formulation, or method, with claims potentially covering composition, use, or manufacturing process. Exact focus depends on claim language, which typically defines the scope narrowly or broadly.
2. How does KR102062357 compare to other patents in similar therapeutic areas?
Its scope may be narrow, specific to a novel compound or formulation, or broader if it claims multiple derivatives or therapeutic uses. The patent landscape in South Korea for pharmaceuticals is competitive, with overlapping patents present in many therapeutic fields.
3. Can this patent be challenged or invalidated?
Yes, through prior art searches and legal procedures that demonstrate lack of novelty or inventive step. Overcoming broad claims or invalidating specific claim elements is a strategic consideration for competitors.
4. What strategic advantages does this patent offer to its holder?
It provides exclusivity in its protected scope within South Korea, potentially enabling market dominance, licensing opportunities, or partnerships—especially if it covers a key API or therapeutic method.
5. How should companies navigate the patent landscape around KR102062357?
They should conduct comprehensive freedom-to-operate analyses, monitor patent filings, and consider licensing or designing around the claims to mitigate infringement risks or capitalize on licensing opportunities.
Sources:
- Korean Intellectual Property Office (KIPO) Patent Database, KR102062357.
- World Intellectual Property Organization (WIPO) Patent Scope Database.
- Patent family and priority document analysis from global patent databases.
Note: Exact claim language and detailed patent specifications should be consulted for precise legal interpretation and strategy development.
